News

Gross profit increased by 69% year-over-year to $3,799,354. As a result of GMP inspection, production had been temporarily suspended during the period ended March 31, 2010, and the

Wellstat Therapeutics said that while no antidote for 5-FU overexposure has been approved by regulatory authorities, Uridine triacetate (formerly known as vistonuridine) has been made available to physicians

Germany will be the second country in the EU in which Ceplene will be commercially available, following the product’s launch in the UK in April, 2010. Ceplene is

According to Jennerex, the presented data demonstrated clear dose-related delivery to solid tumors, cancer-targeted replication and gene expression, and anti-cancer effects of JX-594 delivered IV. Choi (necrotic) responses

Intellipharmaceutics said that the successful manufacture of clinical batches is required to make the drug eligible for Phase I studies and to establish a clinical program in cooperation

As per the terms of the agreement OEP will be responsible for clinical study expenses related to an ASC-J9 Phase IIb multi center trial in acne vulgaris. Scheduled

Swanson said that the reformulation of FemFlora is to address a woman’s complex probiotic needs. The new Swanson Ultra FemFlora contains multiple lactobacilli species to support the flora

Eli Lilly said that the Phase II study evaluated the use of Tasisulam as a second-line treatment in patients with unresectable or metastatic melanoma. The trial’s primary objective

According to the Genentech, the PRIMA study enrolled patients with previously untreated advanced follicular lymphoma. After two-years of follow-up, 82% of patients who received Rituxan maintenance were in